Vascular Biogenics (VBLT) Short Interest Ratio & Short Volume

Short interest is the volume of Vascular Biogenics shares that have been sold short but have not yet been closed out or covered. As of September 30th, investors have sold 250,300 shares of VBLT short. Learn More on Vascular Biogenics' current short interest.

Vascular Biogenics saw a decline in short interest during the month of September. As of September 30th, there was short interest totaling 250,300 shares, a decline of 6.3% from the previous total of 267,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Vascular Biogenics: Travere Therapeutics, Inc. (15.50%), Annexon, Inc. (4.54%), Acelyrin, Inc. (12.80%), Theravance Biopharma, Inc. (14.72%), Larimar Therapeutics, Inc. (5.69%), Neurogene Inc. (8.58%), Fulcrum Therapeutics, Inc. (4.07%), Entrada Therapeutics, Inc. (9.71%), PepGen Inc. (1.25%), Korro Bio, Inc. (2.58%),

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.11 billion), Charter Communications, Inc. ($3.68 billion), T-Mobile US, Inc. ($3.56 billion), Canadian Natural Resources Limited ($3.54 billion), Occidental Petroleum Co. ($3.02 billion), Tractor Supply ($2.29 billion), Rivian Automotive, Inc. ($2.10 billion), Moderna, Inc. ($1.91 billion), Celsius Holdings, Inc. ($1.84 billion), and Royal Caribbean Cruises Ltd. ($1.76 billion). View all of the most shorted stocks.

Short selling VBLT is an investing strategy that aims to generate trading profit from Vascular Biogenics as its price is falling. VBLT shares are trading down $0.53 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Vascular Biogenics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VBLT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VBLT, twice per month. The most recent reporting period available is September, 30 2023.